Mounjaro maker wants NHS drug price rises in return for more investment in UK

The Guardian·Mar 30

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The manufacturer of the drug Mounjaro is seeking higher prices for its drugs from the NHS in exchange for increased investment in the UK. However, reports on the pricing of Mounjaro itself are conflicting, with some outlets suggesting a potential price hike and others indicating a possible discount in UK pharmacies. The situation regarding the drug's price in the UK remains unclear.

Full coverage

Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports

Reuters·Mar 29

Mounjaro fat jab maker Eli Lilly calls for NHS price hikes

MSN·18h ago

Eli Lilly wants hike in NHS drug prices to lift pause on UK investments

Pharmacy Business·Mar 31

Mounjaro fat jab maker Eli Lilly calls for NHS price hikes in return for resuming investment in the UK

This is Money·Mar 30

Price of Mounjaro could be discounted in UK pharmacies

BBC·Aug 28

Trump complaint leads to Mounjaro price increase in UK

The Times·Aug 14

Cost of weight-loss drug Mounjaro to be discounted in UK pharmacies when price hike comes into force, Sky News learns

Sky News·Aug 29

How Mounjaro users are getting around the exorbitant price rises

The Telegraph·Oct 7

View original report at The Guardian ↗

Fetching the latest headlines…